Geoffrey D. Keeler

Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid

Koen Vercauteren, Brad E. Hoffman, Irene Zolotukhin et al. · Molecular Therapy · 2016 · 114 citations · Full text

Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis

Geoffrey D. Keeler, Sandeep Kumar, Brett Palaschak et al. · Molecular Therapy · 2017 · 91 citations · Full text

Type I IFN Sensing by cDCs and CD4+ T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8+ T Cells

Jamie L. Shirley, Geoffrey D. Keeler, Alexandra Sherman et al. · Molecular Therapy · 2019 · 70 citations · Full text

Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing

Hua Yang, Keyun Qing, Geoffrey D. Keeler et al. · Molecular Therapy — Nucleic Acids · 2020 · 28 citations · Full text

AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo

Ling Yin, Geoffrey D. Keeler, Yuanhui Zhang et al. · Gene Therapy · 2020 · 25 citations · Full text

Aav3-mirna Vectors, Hepatology, Growth Suppression +10